INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

71,174 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
BW
Baumgartner Jeffrey WEVP, R&D
CRUSCIRRUS LOGIC, INC.
Open-market sale · 10b5-1 plan
SELL$126K
1,166 sh
Oct 20, 2026Oct 21, 2026
Page 196 of 1780
← PrevNext →
traded Oct 20, 2026
+1d
SEC Form 4

Evidence

8
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$189K
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

8
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
320 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

8
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
59 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

7
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$3.90M
73.5K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

7
SS
Sijbrandij SytseDirector
GTLBGitlab Inc.
Open-market sale · 10b5-1 plan
SELL$2.29M
42.7K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

7
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$1.11M
13.8K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

6
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M$61K
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

6
PJ
Prahm JeremyChief Investment Officer
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$60K
5,610 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
3,505 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
8,897 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
12.1K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Disposition to issuer
D—
4,162 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

5
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$9,197
115 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$920K
11.5K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$191K
2,388 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

4
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
2,869 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

4
AH
Anderson David HugoDirector
NWNNorthwest Natural Holding Co
Open-market sale · 10b5-1 plan
SELL$73K
1,500 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

4
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$506K
4,302 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
GA
Garefis AmyEVP, Chief People Officer
ZIPZIPRECRUITER, INC.
Open-market sale · 10b5-1 plan
SELL$36K
7,879 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
PD
Piscitelli DominicChief Financial Officer
ORICOric Pharmaceuticals, Inc.
Option exercise · 10b5-1 plan
M—
14.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$2,485
100 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

1
GN
Ghamsari NimaDirector, HEAD OF BLEND
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
27.8K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$151K
5,999 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

1
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$150K
5,882 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

1
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$4,397
55 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

1
MK
Malady KyleEVP and Group CEO-VZ Business
VZVERIZON COMMUNICATIONS INC
Open-market sale · 10b5-1 plan
SELL$49K
1,100 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M$125K
23.3K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

0
CL
Collins Helen LouiseCHIEF MEDICAL OFFICER
ELVNEnliven Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
5,000 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
4,135 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

0
BK
Bitterman KevinDirector
IRONDisc Medicine, Inc.
Open-market sale · 10b5-1 plan
SELL$21K
266 sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

0
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$89K
6,018 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
4,135 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
4,135 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M$90K
17.9K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

0
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Option exercise · 10b5-1 plan
M$22K
3,000 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
4,172 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Derivative conversion · 10b5-1 plan
C—
4,172 sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M—
23.3K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

0
LB
Leach BryanDirector, CEO AND PRESIDENT, 10% Owner
IBTAIbotta, Inc.
Option exercise · 10b5-1 plan
M$28K
5,266 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence